A letter from AC Cartwright, Department of Health and Social Security to RB Christie, Armour Pharmaceutical Company Ltd regarding Armour's application through the community concentration procedure for Monoclate Lyophilised Powder. Details the safety profile of the product and steps taken to make the product more safe. Lists objections to the product relating to quality.